FCPM III Services B.V.

In its 13F for Q3 2025 (holdings as of September 30, 2025, filed November 14, 2025), FCPM III Services B.V. reported 9 stock positions worth $500.4 million. Its top holding was Newamsterdam Pharma (NAMS) at 52.4% of the portfolio, followed by Dyne Therapeutics (DYN, 13.8%) and Engene (ENGN, 13.1%). Compared with Q2 2025, it opened 1 new position, added to 1 and reduced 2. The biggest buy was a new position in Vor Biopharma (VOR) and the biggest sale Newamsterdam Pharma (NAMS, shares −13%).

Most Recent 13F
Q2 2026
Location
NAARDEN, P7
CIK
0002013410
Portfolio Value
$500.4M (Q3 2025)
SEC Filing
0001193125-25-281853 ↗ filed Nov 14, 2025

Holdings Value

0$200.0M$400.0M$600.0M$800.0M Q1 2024: $707.3M Q1 2024 Q2 2024: $678.1M Q2 2024 Q3 2024: $582.3M Q3 2024 Q4 2024: $592.4M Q4 2024 Q1 2025: $413.7M Q1 2025 Q2 2025: $369.2M Q2 2025 Q3 2025: $500.4M $500.4M Q3 2025 Q4 2025: $762.9M Q4 2025 Q1 2026: $722.2M Q1 2026 Q2 2026: $750.4M Q2 2026

Holdings 9 stocks · $500.4M

NAMS Newamsterdam Pharma Co. NV 52.36% 9,212,384 $262.0M Reduce -13.3%
DYN Dyne Therapeutics Inc. 13.81% 5,462,846 $69.1M No change
ENGN Engene Holdings Inc. 13.15% 9,632,561 $65.8M No change
ATXS Astria Therapeutics Inc. 5.98% 4,107,537 $29.9M No change
BCYC Bicycle Therapeutics PLC-ADR 5.34% 3,452,330 $26.7M No change
VOR Vor Biopharma Inc. 3.70% 379,640 $18.5M New
REPL Replimune Group Inc. 3.48% 4,158,368 $17.4M Add +6.4%
RAPT Rapt Therapeutics Inc. 1.77% 344,237 $8.9M Reduce -21.8%
ENGENE HOLDINGS INC 0.41% 2,878,148 $2.1M No change

Portfolio Sells Q2 2025 → Q3 2025

NAMS Newamsterdam Pharma Co. NV Reduce -13.3% 52.36% +0.20
RAPT Rapt Therapeutics Inc. Reduce -21.8% 1.77% +0.84

Portfolio Buys Q2 2025 → Q3 2025

VOR Vor Biopharma Inc. New 3.70% +3.70
REPL Replimune Group Inc. Add +6.4% 3.48% −6.36

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 11$750.4MNAMS, MPLT, DYN, VOR, DMRA
Q1 2026 10$722.2MNAMS, DYN, VOR, ENGN, MPLT
Q4 2025 10$762.9MNAMS, DYN, ENGN, RAPT, MPLT
Q3 2025 9$500.4MNAMS, DYN, ENGN, ATXS, BCYC
Q2 2025 8$369.2MNAMS, DYN, REPL, ENGN, BCYC
Q1 2025 7$413.7MNAMS, DYN, ENGN, REPL, BCYC
Q4 2024 8$592.4MNAMS, DYN, ENGN, BCYC, REPL
Q3 2024 7$582.3MDYN, NAMS, ENGN, REPL, BCYC
Q2 2024 7$678.1MDYN, NAMS, ENGN, REPL, BCYC
Q1 2024 6$707.3MNAMS, DYN, ENGN, REPL, ENGENE HOLDINGS INC